Aphria Inc (NYSE:APHA) has earned a consensus recommendation of “Buy” from the nine brokerages that are presently covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $14.75.
A number of equities analysts have recently commented on the stock. Clarus Securities assumed coverage on shares of Aphria in a report on Tuesday, April 16th. They issued a “buy” rating and a $22.75 price target on the stock. Jefferies Financial Group reissued a “buy” rating and issued a C$15.00 price target on shares of Aphria in a report on Friday, May 24th. Zacks Investment Research raised shares of Garrett Motion from a “sell” rating to a “hold” rating in a report on Friday, May 10th. Finally, ValuEngine raised shares of ZTE CORP/ADR from a “hold” rating to a “buy” rating in a report on Monday, April 15th.
Several large investors have recently modified their holdings of the company. Advisory Services Network LLC increased its holdings in shares of Aphria by 45.3% in the 1st quarter. Advisory Services Network LLC now owns 5,625 shares of the company’s stock worth $52,000 after buying an additional 1,755 shares during the last quarter. Shell Asset Management Co. boosted its stake in shares of Aphria by 17.9% in the 1st quarter. Shell Asset Management Co. now owns 17,723 shares of the company’s stock valued at $165,000 after purchasing an additional 2,687 shares in the last quarter. Financial Advocates Investment Management purchased a new stake in shares of Aphria in the 4th quarter valued at $89,000. Creative Planning boosted its stake in shares of Aphria by 6.4% in the 1st quarter. Creative Planning now owns 72,342 shares of the company’s stock valued at $674,000 after purchasing an additional 4,351 shares in the last quarter. Finally, Cetera Advisor Networks LLC boosted its stake in shares of Aphria by 15.1% in the 1st quarter. Cetera Advisor Networks LLC now owns 35,717 shares of the company’s stock valued at $340,000 after purchasing an additional 4,684 shares in the last quarter. 8.56% of the stock is currently owned by hedge funds and other institutional investors.
Aphria stock opened at $6.22 on Thursday. The business’s 50 day moving average price is $6.91. The company has a market cap of $1.56 billion, a price-to-earnings ratio of 44.43 and a beta of 3.12. Aphria has a 1-year low of $3.75 and a 1-year high of $16.86.
Aphria (NYSE:APHA) last posted its earnings results on Monday, April 15th. The company reported ($0.15) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.04) by ($0.11). The company had revenue of $55.24 million for the quarter, compared to analyst estimates of $41.11 million. On average, analysts forecast that Aphria will post -0.13 EPS for the current year.
Aphria Company Profile
Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.
Further Reading: What is the price-sales ratio?
Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.